Dr. Roy Artal, M.D.
Pulmonology (Pulmonary Disease Physician)
8635 W 3rd St, Suite 965w
Los Angeles, CA 90048
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of California, Geffen School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 885
Licensed in California since 1996, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: University of California, Geffen School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
CA license A60669 (first issued 1996; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
Medical groups
- Cedars-Sinai Medical Care Foundation (1,692 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 885
- Services billed
- 2,064
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 458 | 232 |
| Established patient office or other outpatient visit, 20-29 minutes | 445 | 347 |
| Established patient office or other outpatient visit, 30-39 minutes | 361 | 264 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 122 | 43 |
| Established patient office or other outpatient visit, 40-54 minutes | 105 | 89 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 101 | 42 |
| New patient office or other outpatient visit, 45-59 minutes | 101 | 101 |
| Sleep study in sleep lab (6 years or older) | 100 | 90 |
| Sleep study including heart rate, breathing, and sleep time | 88 | 69 |
| Therapy procedure using a positive pressure ventilator | 84 | 66 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Fluticasone Propionate Other prescribers in Los Angeles, CA | 67 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Los Angeles, CA | 56 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Los Angeles, CA | 52 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Los Angeles, CA | 40 |
| Azelastine Hcl Other prescribers in Los Angeles, CA | 35 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Los Angeles, CA | 30 |
| Prednisone Other prescribers in Los Angeles, CA | 29 |
| Modafinil Other prescribers in Los Angeles, CA | 28 |
| Incruse Ellipta (umeclidinium bromide) Other prescribers in Los Angeles, CA | 27 |
| Montelukast Sodium Other prescribers in Los Angeles, CA | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 22 payments worth $12,548 in total to this clinician.
| Jazz Pharmaceuticals Inc. | $12,223 |
|---|---|
| Inspire Medical Systems, Inc. | $325 |
| Compensation for services other than consulting (speaking, faculty) | $10,200 |
|---|---|
| Food and Beverage | $1,175 |
| Travel and Lodging | $1,023 |
| Consulting Fee | $150 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) XYWAV · NEUROLOGY | $4,590 |
| Jazz Pharmaceuticals Inc. Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) XYWAV · NEUROLOGY | $3,060 |
| Jazz Pharmaceuticals Inc. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) XYWAV · NEUROLOGY | $2,550 |
| Jazz Pharmaceuticals Inc. Apr 25, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Scottsdale, AZ · in-kind | $386 |
| Jazz Pharmaceuticals Inc. Apr 25, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Scottsdale, AZ · in-kind | $335 |
| Jazz Pharmaceuticals Inc. Apr 25, 2025 | Travel and Lodging XYWAV · NEUROLOGY · travel to Scottsdale, AZ · in-kind | $302 |
| Jazz Pharmaceuticals Inc. Feb 13, 2025 | Consulting Fee XYWAV; XYREM · NEUROLOGY | $150 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.